News
See photo galery Friday June 6
See photo galery Saturday June 7
Dr. Veronique Gouverneur Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Veronique Gouverneur gave a lecture at The Ojima Distinguished Lectureship Award
in Chemistry on April 25 at the Wang Center, SBU.(Read more)
ICB&DD Welcomes New Members: Drs. Jeffrey Gustafson and Wenchao Qu
Dr. Jeffrey Gustafson, Professor of Department of Chemistry
Dr. Wenchao Qu, Associate Professor of Department of Psychiatry, Stony Brook Renaissance
School of Medicine
Drug to Treat Neuropathy Advances in Clinical Trials
The drug, ART26.12, is being developed by Artelo Biosciences, based in Solana Beach, CA. The compound was discovered and initially developed by Drs., Iwao Ojima and Martin Kaczocha (read more)
ICB&DD 18th Annual Symposium "Frontiers of Neuroscience and Drug Discovery" (read more)
New Drug to Control Pain Related to Cancer Treatment Originally Developed at Stony Brook Gets FDA Clearance (read more)
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor (Read more )
ICB&DD Welcomes New Member: Dr. Ivet Bahar
Dr. Ivet Bahar, Professor, Department of Biochemistry and Cell Biology, Louis and Beatrice Laufer
Endowed Chair
Director, Laufer Center for Physical and Quantitative Biology (read more)
Dr. Hiroaki Suga Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Hiroaki Suga gave a lecture at The Ojima Distinguished Lectureship Award in Chemistry
on April 26 at the Wang Center, SBU. (Read more)
Advancing Technology to Improve the Therapeutic Effect of Radionuclide Therapy for Cancer
Dr, Jacob Houghton, ICB&DD Member and Assistant Professor in the Department of Radiology
in the Renaissance School of Medicine (RSOM), and researcher in the Stony Brook Cancer
Center, conducts research on targeted radionuclide therapy for diagnosing and treating
cancer. (Read more)
ICB&DD Welcomes New Members: Drs. Anissa Abi-Dargham, Stuti Sharma and Markus Riessland
Dr. Anissa Abi-Dargham, Distinguished Professor and The Lourie Endowed Chair, Department of Psychiatry and Behavioral Health, Stony Brook Renaissance School
of Medicine
Dr. Stuti Sharma, Assistant Professor, Department of Biochemistry and Cell Biology, Stony Brook Renaissance
School of Medicine
Dr. Markus Riessland , Assistant Professor, Department of Neurobiology and Behavior, Stony Brook Renaissance
School of Medicine
Message from the Director
Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD
Welcome to the Institute of Chemical Biology & Drug Discovery
The primary objective of ICB&DD is to establish a world-class “Center of Excellence” in chemical biology and drug discovery at Stony Brook. The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance. ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.
